Skip to main content

Table 1 Self-assessment prior (T0) and post (T1) intervention

From: Virtual patients versus small-group teaching in the training of oral and maxillofacial surgery: a randomized controlled trial

Item T0T1p-Value
Anatomy of the cranio-facial areaSGT3.363.080.075 (M)
VP3.243.210.833 (M)
p-Value0.490.58 
Clinical signs of a mandibular fractureSGT42.92<.001 (M)
VP3.942.91<.0001 (M)
p-Value0.940.96 
Diagnostic approach of mandibular fracturesSGT4.242.88<.0001 (M)
VP4.353.03<.0001 (M)
p-Value0.370.54 
Therapy of mandibular fracturesSGT4.22.92<.0001 (M)
VP4.263.03<.0001 (M)
p-Value0.580.60 
Diagnostic approach of midfacial fracturesSGT4.523.08<.0001 (M)
VP4.683.12<.0001 (M)
p-Value0.3030.936 
Therapy of midfacial fracturesSGT4.63.12<.0001 (M)
VP4.623.29<.0001 (M)
p-Value0.6240.502 
Clinical signs of oro-facial infectionsSGT4.043.08<.001 (M)
VP4.062.74<.0001 (M)
p-Value0.9040.118 
Diagnostic approach of oro-facial infectionsSGT4.323.2<.001 (M)
VP4.412.97<.0001 (M)
p-Value0.6590.271 
Therapy of oro-facial infectionsSGT4.283.04<.001 (M)
VP4.503.00<.0001 (M)
p-Value0.4060.771 
Risk factors for the development of malignant head and neck tumorsSGT3.882.96<.001 (M)
VP3.852.94<.001 (M)
p-Value0.9920.880 
Clinical signs of malignant head and neck tumoursSGT4.163<.001 (M)
VP4.242.97<.0001 (M)
p-Value0.6310.825 
Diagnostic approach of malignant head and neck tumoursSGT4.163.12<.001
VP4.323.15<.0001
p-Value0.5550.857 
Therapy of malignant head and neck tumoursSGT4.283.28<.001
VP4.563.15<.0001
p-Value0.3470.610 
  1. Data are presented as Mean. Participants rated their knowledge using a 6-point likert scale ranging from “1 = very good “to “6 = insufficient”
  2. (M) = Mann-Whitney-White U test for ordinally distributed data
  3. (T0) = prio to the intervention, (T1) = directly after the intervention
  4. Significant results were marked in boldface